In the version of this article initially published online, Alberto Bardelli's e-mail address was incorrect. The correct address is alberto.bardelli@unito.it. The error has been corrected in the print, PDF and HTML versions of this article.
Additional information
The online version of the original article can be found at 10.1038/nm.3870
Rights and permissions
About this article
Cite this article
Siravegna, G., Mussolin, B., Buscarino, M. et al. Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med 21, 827 (2015). https://doi.org/10.1038/nm0715-827b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0715-827b
This article is cited by
-
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
Journal of Cancer Research and Clinical Oncology (2023)
-
Liquid biopsy: current technology and clinical applications
Journal of Hematology & Oncology (2022)
-
Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment
British Journal of Cancer (2022)
-
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
British Journal of Cancer (2022)
-
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers
Cancer Chemotherapy and Pharmacology (2022)